Association for Diagnostics & Laboratory Medicine

The Association for Diagnostics & Laboratory Medicine (formerly known as the American Association for Clinical Chemistry or AACC) is a global scientific society dedicated to clinical laboratory science and its application to healthcare. ADLM's current president is Octavia M. Peck Palmer, PhD, FAAC, and the association headquarters are located in Washington, D.C. (United States).[1][2]

Association for Diagnostics & Laboratory Medicine
AbbreviationADLM
Formation1948 (1948)
PurposeAcademic
HeadquartersWashington, D.C., USA
Membership
8,000 (2015)
President
Octavia M. Peck Palmer
Websitewww.myadlm.org
Formerly called
American Association for Clinical Chemistry

ADLM Members

ADLM's approximately 8,000 members come from all areas of lab medicine—clinical and research laboratories, diagnostic companies, government agencies, original equipment manufacturers, and more. Collectively they develop and run lab tests and lab instruments used throughout healthcare. They also manage labs, conduct research involving biomarkers, and promote accurate diagnostic testing. ADLM represents the diverse interests of a global lab community: its members come from 110 countries and hold the spectrum of lab-related professional degrees, certifications, and credentials.[3][4]

ADLM Annual Scientific Meeting

ADLM holds several scientific conferences each year, the largest of which is the ADLM Annual Scientific Meeting & Clinical Lab Expo. First held in 1949, this educational meeting and technology exposition is an event in the field of laboratory medicine, attracting an average of 20,000 participants.[5][6]

Clinical Chemistry

ADLM's journal is a journal of clinical laboratory science.

The Journal of Applied Laboratory Medicine

Launched by ADLM in 2016, it is an international, peer-reviewed publication.

Clinical Laboratory News

Published since 1975.

Controversy

At the 68th AACC Annual Scientific Meeting in 2016, Elizabeth Holmes, CEO and founder of Theranos, spoke at what AACC described as a “special session.”[7] Holmes, who the Centers for Medicare and Medicaid Services (CMS) had recently been banned from owning, operating or directing a blood testing service for a period of two years, was invited to present scientific data on her company's much discussed Edison device.[8][9] Instead, Holmes took the opportunity to unveil a new product dubbed miniLab.[10] Several people on the Theranos scientific advisory board were members of the association.[11][8][12][13][14][15]

COVID-19 pandemic

ADLM members who are frontline laboratory specialists also encounter significant challenges in carrying out such studies. Lack of product selection and research materials as well as personal protective equipment, known as PPE, are the most important of these barriers. In recognition of these obstacles to optimizing research ability, ADLM sent a letter to the Coronavirus Task Force advising the Task Force and White House to minimize supply chain issues, and to identify and organize tools such that doctors, nurses, laboratory personnel and other healthcare staff may do their jobs.[16]

ADLM has produced instructional videos demonstrating serology, treatment of polymerase chain reaction (PCR), and more through research in the spotlight during the COVID-19 pandemic.[17]

References

  1. "AACC Board of Directors". aacc.org. Retrieved 30 August 2019.
  2. "American Association for Clinical Chemistry". glassdoor.com. Retrieved 21 March 2014.
  3. "Lab Stakeholders Urge CMS Oversight of NGS Tests as FDA Ponders New Reg Scheme". April 6, 2015.
  4. "AACC expresses concerns to FDA regarding overregulation of next-generation sequencing tests". March 20, 2015.
  5. "Research on Personalized Medicine, Global Health, and Portable Tests Draws More Than 20,000 Attendees to the 70th AACC Annual Scientific Meeting - AACC.org". www.aacc.org. Retrieved 2019-08-30.
  6. "AACC Annual Meeting & Clinical Lab Expo Named the Fastest Growing Trade Show by Trade Show News Network" (Press release). prnewswire.com. Retrieved 21 March 2014.
  7. “Theranos Science and Technology: The Miniaturization of Lab Testing” ‘’AACC,org’’, 1 August 2016, Retrieved 31 August 2016.
  8. Christensen, Jen (3 August 2016). "Skeptical reaction at Theranos' coming out party". CNN. Retrieved 31 August 2016.
  9. Carreyrou, John (18 May 2016). "Theranos Voids Two Years of Edison Blood-Test Results". Wall Street Journal. Retrieved 31 August 2016.
  10. "With chance to soothe Theranos' critics with data, Holmes gives sales pitch". Ars technica. 2 August 2016.
  11. George, John (2 August 2016). "Theranos CEO unveils 'miniLab' at Philadelphia conference". Philadelphia Business Journal. Retrieved 31 August 2016.
  12. Kolhatkar, Sheelah (2 August 2016). "The Founder of Theranos Tries to Change the Subject". The New Yorker. Retrieved 31 August 2016.
  13. Carreyrou, John (1 August 2016). "Theranos Makes Case to Laboratory Experts". The Wall Street Journal. Retrieved 31 August 2016.
  14. Friedman, Bruce (10 August 2016). "Janet Kreizman, CEO of AACC, Responds to Previous Blog Notes about Theranos". Lab Soft News. Retrieved 31 August 2016.
  15. Parloff, Roger (7 April 2016). "Theranos Adds Startlingly Well-Qualified Medical Board". Fortune. Retrieved 31 August 2016.
  16. "AACC Commends Congress for Including Funding for Testing Improvements in the Latest Coronavirus Relief Package". Cision PR Newswire. 23 April 2020. Archived from the original on 2020-04-27. Retrieved 6 May 2020.
  17. "AACC educates on antibody testing for coronavirus and more". LabPulse. 30 April 2020. Archived from the original on 2020-09-25. Retrieved 6 May 2020.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.